崙棫堛栻昳怘昳塹惗尋媶強 National Institute of Health Sciences
惗暔栻昳晹 Division of Biological Chemistry and Biologicals
丂丂丂
亂rINN亃girentuximab (List 63, 2010, Vol.24, No. 1, p57)
亂pINN亃girentuximab (List 101, 2009, Vol.23, No. 2, p147)

亂夝愢乮榓栿乯亃
IgG1內, 峈僸僩扽巁扙悈峺慺IX(TGFB丆TGFbeta枖偼TGF-beta丏TGF-beta-1枖偼TGFB1, TGF-beta-2丆TGFB2枖偼G-TsF丆媦傃TGF-beta-3枖偼TGFB3傪娷傓), 僉儊儔儌僲僋儘乕僫儖峈懱; 峈庮釃栻丏
H嵔 (兞1嵔丆1-449)丗[Mus musculus VH (IGHV5-6-2*01 -(IGHD)-IGHJ4*01) [8.8.12] (1-119) -Homo sapiens IGHG1*01 (120-449)]丏
L嵔(內嵔丆1'-214')丗[Mus musculus V-KAPPA (IGKV6-13*01 -IGKJ1*01) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (108'-214')]丏
僕僗儖僼傿僪寢崌偺埵抲丗222-214', 228-228''丆231-231''
摐嵔晅壛埵抲 299, 299''

亂暘巕幃亃C
6460H10006N1718O2018S48

亂CAS斣崋亃916138-87-9

亂JAN亃枹廂嵹
Copyright (C) 丂丂丂Division of Biological Chemistry and Biologicals丂丂丂All rights reserved.